Daniel A. Spyker, PhD, MD | Psychiatrist.com

Original Research

Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

January 25, 2011

Michael H. Allen, David Feifel, Michael D. Lesem, et al